Stoke Therapeutics STOK
NASDAQ STOK
$26.39 +0.39 (+1.50%)
As of: Oct 1, 2026 · 12:46 PM EDT

Stoke Therapeutics (STOK) Other Non-Current Liabilities (2021 - 2026)

Updated

Stoke Therapeutics (STOK) recorded Other Non-Current Liabilities of $837,000 in Q2 2026, down 33.3% from $1.26 million a year earlier and down 15.5% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Stoke Therapeutics reported Other Non-Current Liabilities of $1.14 million, down 54.0% from FY2024.

  • Annual Other Non-Current Liabilities has a four-year compound annual growth rate of -26.7% (FY2021 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $2.48 million in FY2024 (-49.3%), $4.88 million in FY2023 (+64.6%), $2.97 million in FY2022 (-24.8%) and $3.95 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2021.
  • On a year-over-year basis, Other Non-Current Liabilities has declined for seven consecutive quarters, with an average decline of 15.6% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 218.0% in Q3 2024, against a decline of 73.4% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $991,000 (Q1 2026), $1.14 million (Q4 2025) and $1.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 837,000.00
Mar 31, 2026 991,000.00
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.87 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.05 Mn
Jun 30, 2024 3.61 Mn
Mar 31, 2024 4.21 Mn
Dec 31, 2023 4.88 Mn
Sep 30, 2023 959,000.00
Jun 30, 2023 1.63 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 2.97 Mn
Sep 30, 2022 3.61 Mn
Jun 30, 2022 4.25 Mn
Mar 31, 2022 3.51 Mn
Dec 31, 2021 3.95 Mn
API Access

Stoke Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=STOK&period=max&api_key=YOUR_API_KEY